Octapharma is an independent, global plasma fractionation specialist. Founded in 1983, the company has grown to employ around 2000 people in more than 25 countries. We have state-of-the-art production facilities in Austria, France, Sweden, Germany and Mexico. Our products are available in more that 75 countries around the world.
Our mission statement: For the safe and optimal use of human proteins.
We would like to welcome you to our booth during Medicine-2008 exhibition!
Octapharma provides a complete range of safe, tolerable, efficacious and cost-effective human plasma-derived pharmaceutical products.
octanate® - Double virus-inactivated, high-purity factor VIII-von Willebrand factor (VWF) concentrate for prophylaxis and treatment of bleeds in hemophilia A patients. Available in 250 IU, 500 IU and 1000 IU presentations.
octanine®-F and nanotiv - High-purity SD-treated and nanofiltered factor IX concentrates for prophylaxis and treatment of bleeds in hemophilia B patients. Available in 250 IU (Octanine F), 500 IU and 1000 IU presentations.
wilate® - A new generation VWF/FVIII-concentrate for the treatment of von Willebrand disease and hemophilia A. In addition to SD treatment, Wilate undergoes terminal dry-heat treatment (100 ºC for 120 minutes, PermaHeat). Wilate is available as 450 IU FVIII / 400 IU VWF (to be dissolved in 5 mL) and 900 IU FVIII / 800 IU VWF (to be dissolved in 10 mL).
octagam® - SD- and pH4-treated IVIG in a ready-to-use 5% formulation with a shelf life of 24 months at room temperature. Octagam does not contain sucrose. Available in 1 g, 2.5 g, 5 g and 10 g presentations.
rhesonativ® - SD-treated anti-D immunoglobulin for prophylaxis of Rh immunization in Rh-negative women in connection with pregnancy and delivery. Available in a 1250 IU (250 mcg) presentation.
Albumin/octalbin® - 5 and 20% albumin solution.
Albumin is used for restoration and maintenance of circulating blood volume where volume deficiency has been demonstrated.
atenativ® - SD- and heat-treated high purity antithrombin concentrate for treatment of coagulation disturbances in connection with inherited and acquired antithrombin deficiency. Available in 500 IU and 1000 IU presentations.
octaplas® - Pharmaceutically licensed, SD-treated, fresh frozen plasma for trans-fusion. Octaplas has a standardized content of coagulation factors. Available in 200 mL bags in A, B, AB and O blood groups.
octaplex® - SD treated and nanofiltered prothrombin complex concentrate for treatment of acquired deficiency of the prothrombin complex coagulation factors, such as deficiency caused by treatment with vitamin K antagonists, when rapid correction of the deficiency is required. Available in a 500 IU (factor IX) presentation.